Recludix Pharma
About:
Recludix pharma is a developing platform to treat cancer patients.
Website: https://recludixpharma.com
Top Investors: New Enterprise Associates, Access Biotechnology, Westlake Village BioPartners
Description:
Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.
Total Funding Amount:
$60M
Headquarters Location:
San Diego, California, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)recludix.com
Founders:
Brian Hodous, Patrick Zarrinkar
Number of Employees:
11-50
Last Funding Date:
2021-11-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai